Clinical trial
A Study in Adults With Untreated Acute Lymphoblastic Leukemia
NCT00136435 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00136435 |
|---|---|
| Title | A Study in Adults With Untreated Acute Lymphoblastic Leukemia |
| Official title | A Multicenter Phase II Study in Adults With Untreated Acute Lymphoblastic Leukemia: Testing Pharmacokinetically Individualized Doses of L-Asparaginase Following the Dana Farber Cancer Institute (DFCI) Pediatric Consortium Protocol |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital Queen Elizabeth II Health Sciences Centre |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | prednisone, doxorubicin, vincristine, methotrexate, asparaginase, dexamethasone, cranial radiation, leucovorin, cytarabine, hydrocortisone and 2 more |
| Enrollment | 100 |
| Start date | Jun 1, 2002 |
| Primary completion | Nov 1, 2008 |
| Completion | May 1, 2011 |
| First posted | Aug 29, 2005 |
| Last update posted | Oct 20, 2025 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: